IGF-I specifically enhances axon outgrowth of corticospinal motor neurons

Corticospinal motor neurons (CSMN) are among the most complex CNS neurons; they control voluntary motor function and are prototypical projection neurons. In amyotrophic lateral sclerosis (ALS), both spinal motor neurons and CSMN degenerate; their damage contributes centrally to the loss of motor function in spinal cord injury. Direct investigation of CSMN is severely limited by inaccessibility in the heterogeneous cortex. Here, using new CSMN purification and culture approaches, and in vivo analyses, we report that insulin-like growth factor-1 (IGF-I) specifically enhances the extent and rate of murine CSMN axon outgrowth, mediated via the IGF-I receptor and downstream signaling pathways; this is distinct from IGF-I support of neuronal survival. In contrast, brain-derived neurotrophic factor (BDNF) enhances branching and arborization, but not axon outgrowth. These experiments define specific controls over directed differentiation of CSMN, indicate a distinct role of IGF-I in CSMN axon outgrowth during development, and might enable control over CSMN derived from neural precursors.

[1]  A. Aguayo,et al.  Axonal elongation into peripheral nervous system "bridges" after central nervous system injury in adult rats. , 1981, Science.

[2]  J. Milbrandt,et al.  Differential expression of insulin-like growth factor genes in rat central nervous system. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[3]  C. Bondy,et al.  Transient IGF-I gene expression during the maturation of functionally related central projection neurons , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[4]  E. Bloch-Gallego,et al.  Survival in vitro of motoneurons identified or purified by novel antibody-based methods is selectively enhanced by muscle-derived factors. , 1991, Development.

[5]  P. Porcu,et al.  Inhibition of cellular proliferation by peptide analogues of insulin-like growth factor 1. , 1992, Cancer research.

[6]  W. Lee,et al.  Patterns of Insulin‐like Growth Factor and IGF Receptor Gene Expression in the Brain: Functional Implications , 1993, Annals of the New York Academy of Sciences.

[7]  M. E. Lewis,et al.  Insulin-like growth factors: putative muscle-derived trophic agents that promote motoneuron survival. , 1993, Journal of neurobiology.

[8]  J. Baker,et al.  Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r) , 1993, Cell.

[9]  Y. Fujita-Yamaguchi,et al.  Two new monoclonal antibodies against the alpha subunit of the human insulin-like growth factor-I receptor. , 1993, Biochemical and biophysical research communications.

[10]  Elizabeth J. Robertson,et al.  Role of insulin-like growth factors in embryonic and postnatal growth , 1993, Cell.

[11]  SK McConnell,et al.  Regulation of the POU domain gene SCIP during cerebral cortical development , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[12]  A. Meyer-Franke,et al.  Characterization of the signaling interactions that promote the survival and growth of developing retinal ganglion cells in culture , 1995, Neuron.

[13]  F. Hefti,et al.  Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons , 1995, Neuron.

[14]  T. Nam,et al.  Role of insulin-like growth factor binding proteins in the control of IGF actions. , 1995, Progress in growth factor research.

[15]  M. Radeke,et al.  Developmental and mature expression of full‐length and truncated TrkB, receptors in the rat forebrain , 1996, The Journal of comparative neurology.

[16]  S. Korsmeyer,et al.  BAX Is Required for Neuronal Death after Trophic Factor Deprivation and during Development , 1996, Neuron.

[17]  A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. ALS CNTF Treatment Study Group. , 1996, Neurology.

[18]  M. Gaweł,et al.  Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS/IGF-I Study Group. , 1997, Neurology.

[19]  M. Gaweł,et al.  Effect of recombinant human insulin-like growth factor-I on progression of ALS , 1997, Neurology.

[20]  H. Junger,et al.  Neurotrophin-4 (NT-4) and glial cell line-derived neurotrophic factor (GDNF) promote the survival of corticospinal motor neurons of neonatal rats in vitro , 1997, Brain Research.

[21]  J. L. Goldberg,et al.  Neural regeneration: Extending axons from bench to brain , 1998, Current Biology.

[22]  W. Robberecht,et al.  A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS/IGF-I Study Group. , 1998, Neurology.

[23]  P. Leigh,et al.  A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis , 1998, Neurology.

[24]  E. Huang,et al.  Expression of Trk receptors in the developing mouse trigeminal ganglion: in vivo evidence for NT-3 activation of TrkA and TrkB in addition to TrkC. , 1999, Development.

[25]  W. Bradley A controlled trial of recombinant methionyl human BDNF in ALS , 1999, Neurology.

[26]  M. Magistris,et al.  Quantification of upper motor neuron loss in amyotrophic lateral sclerosis , 2000, Clinical Neurophysiology.

[27]  J. O’Kusky,et al.  Insulin-Like Growth Factor-I Promotes Neurogenesis and Synaptogenesis in the Hippocampal Dentate Gyrus during Postnatal Development , 2000, The Journal of Neuroscience.

[28]  J. D. Macklis,et al.  Specific Neurotrophic Factors Support the Survival of Cortical Projection Neurons at Distinct Stages of Development , 2001, The Journal of Neuroscience.

[29]  W. Snider,et al.  Different Signaling Pathways Mediate Regenerative versus Developmental Sensory Axon Growth , 2001, The Journal of Neuroscience.

[30]  M. Meyer,et al.  Endogenous Brain-Derived Neurotrophic Factor and Neurotrophin-3 Antagonistically Regulate Survival of Axotomized Corticospinal Neurons In Vivo , 2001, The Journal of Neuroscience.

[31]  K. Giehl,et al.  Trophic Dependencies of Rodent Corticospinal Neurons , 2001, Reviews in the neurosciences.

[32]  A Compston,et al.  A role for oligodendrocyte‐derived IGF‐1 in trophic support of cortical neurons , 2001, Glia.

[33]  L. C. Katz,et al.  BDNF release from single cells elicits local dendritic growth in nearby neurons , 2002, Nature Neuroscience.

[34]  M. Schwab Repairing the Injured Spinal Cord , 2002, Science.

[35]  Ben A. Barres,et al.  Retinal Ganglion Cells Do Not Extend Axons by Default Promotion by Neurotrophic Signaling and Electrical Activity , 2002, Neuron.

[36]  Stephen G Waxman,et al.  Primary cortical motor neurons undergo apoptosis after axotomizing spinal cord injury , 2003, The Journal of comparative neurology.

[37]  F. Gage,et al.  Retrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS Model , 2003, Science.

[38]  Minh N. H. Nguyen,et al.  Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice , 2003, Science.

[39]  J. Olavarria,et al.  Beyond Laminar Fate: Toward a Molecular Classification of Cortical Projection/Pyramidal Neurons , 2003, Developmental Neuroscience.

[40]  M. Schwab Nogo and axon regeneration , 2004, Current Opinion in Neurobiology.

[41]  M. Meyer,et al.  Secreted proNGF is a pathophysiological death-inducing ligand after adult CNS injury. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[42]  L. Bruijn,et al.  Unraveling the mechanisms involved in motor neuron degeneration in ALS. , 2004, Annual review of neuroscience.

[43]  J. D. Macklis,et al.  Neurogenesis of corticospinal motor neurons extending spinal projections in adult mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[44]  P. Arlotta,et al.  Stage‐specific and opposing roles of BDNF, NT‐3 and bFGF in differentiation of purified callosal projection neurons toward cellular repair of complex circuitry , 2004, The European journal of neuroscience.

[45]  J. O’Kusky,et al.  In vivo effects of insulin‐like growth factor‐I (IGF‐I) on prenatal and early postnatal development of the central nervous system , 2004, The European journal of neuroscience.

[46]  Matthew C Kiernan,et al.  Assessment of disease progression in motor neuron disease , 2005, The Lancet Neurology.

[47]  P. Arlotta,et al.  Fezl Is Required for the Birth and Specification of Corticospinal Motor Neurons , 2005, Neuron.

[48]  A. Musarò,et al.  Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model , 2005, The Journal of cell biology.

[49]  Jun Shi,et al.  Ryk-mediated Wnt repulsion regulates posterior-directed growth of corticospinal tract , 2005, Nature Neuroscience.

[50]  Paola Arlotta,et al.  Neuronal Subtype-Specific Genes that Control Corticospinal Motor Neuron Development In Vivo , 2005, Neuron.

[51]  Robert H. Brown,et al.  Molecular biology of amyotrophic lateral sclerosis: insights from genetics , 2006, Nature Reviews Neuroscience.

[52]  A. Cáceres,et al.  IGF-1 receptor is essential for the establishment of hippocampal neuronal polarity , 2006, Nature Neuroscience.